How Stem Cell Research Has Evolved Over the Past Decade

The Life Sciences Report | |

Regenerative medicine through stem cell technology is a source of hope for many suffering from ailments including Alzheimer's disease, diabetes, spinal cord injury and cancer. While new

Why Healthcare Investors Shouldn't Ignore the Booming MedTech Space

The Life Sciences Report | |

Medical technology is not considered a huge-margin investment in the way that the biotech and drug industries are. However, some of today's medtech blurs the line, including hybrid companies

Is Biotech Cooling or Gaining a Second Wind?

The Life Sciences Report | |

It's all about the fundamentals for Jason Napodano, CFA, of Zacks Investment Research. Revenue and earnings at the big biotechs are signaling investors that the market is still strong, and

An Interview with Robert J. Hariri of Celgene Cellular Therapeutics

The Life Sciences Report | |

Neurosurgeon and serial entrepreneur Robert J. Hariri, founder, chairman and chief science officer at Celgene Cellular Therapeutics, describes how his businesses address some of the great unmet

Regenerative Medicine Finally Gets Some Respect: Reni Benjamin

The Life Sciences Report | |

Of the many themes that propelled the biotech sector to record returns in 2013, regenerative medicine and therapeutics targeting cancer were front and center. In this interview with The Life

Stocks Under $10: Sell Rated Biomed/Genetics Companies in the Medical Space

Richard Suttmeier | |

At we show that the Medical sector 10.1% overvalued with the Medical Biomed/Genetics 11.9% overvalued. All 14 stocks in today’s table have complete ValuEngine data and have

StemCells Surges on Completed Clinical Trial for Treatment of Spinal Cord Injuries

Michael Teague | |

Stem Cells, Inc. (STEM) shares soared as high as  29 percent to $2.13 near on Tuesday, after the company outlined its tentatively successful results from a phase I/II clinical trial of an

Equities Sector Coverage: Stocks Overcome Weaker Earnings with Data Boost

Sector Recap | |

Housing Starts surged 15.0% in September to an annual rate of 872,000 with permits up to 894,000. Single Family starts rose 11.0% to 603,000 to the highest pace since August 2008. The Dow Jones

Equities Sector Coverage: Stocks Fall Ahead of Jackson Hole

Sector Recap | |

Initial Jobless Claims were unchanged at 374,000 still above the 350,000 recessionary threshold. Personal Income rose 0.3% in July with Spending up 0.4%. The Dow Jones Industrial Average traded

Equities Sector Coverage: Stocks Close Out Strong First Quarter

Sector Recap | |

Personal Income rose by just 0.2% in February with Spending up 0.8%. This brings the Savings Rate down to 3.7%, the lowest since August 2009. The year over year PCE Price Index was up 2.3%, above


Symbol Last Price Change % Change






INTERVIEW: CEO Jorge Fernandez - iBlades's Sam Mitchell interview iBlades CEO, Jorge Fernandez